Publications

Publications

Filter Results: (926) Arrow Down
Filter Results: (926) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 44 of 926 Results →
  • 07 Apr 2003
  • Research & Ideas

XTV: Xerox’s Attempted Recovery From “Fumbling the Future”

because they were built with proprietary components, a manifestation of Xerox's approach to systems design. The development costs of these proprietary components had to be borne by the low unit volumes of its printers, in contrast to View Details
Keywords: by Henry Chesbrough
  • 01 Sep 2014
  • News

All For One

industries as diverse as automobiles and pharmaceuticals and began to interview and observe them to see how they created environments ripe for innovation. “We didn’t want to just espouse platitudes,” Hill... View Details
Keywords: Michael Blanding; faculty; research; Market Research, Photo, Translation, Veterinary and Other Services; Professional Services
  • 26 Apr 2011
  • Op-Ed

HBS Faculty Comment on Environmental Issues for Earth Day

what we have learned about how best to accelerate innovation from industries like IT and pharmaceuticals - sectors in which the US leads the world and which saw enormous rates of technical progress over the... View Details
Keywords: by Staff; Energy; Utilities
  • September 2019
  • Case

Bill & Melinda Gates Foundation: Shaping the Vaccine Manufacturing Ecosystem

By: Willy C. Shih
Vaccines for children has been a long-standing focus for the Bill & Melinda Gates Foundation, and its critical role in public health made its production an important economic and political issue. This case describes the Foundation's investment in a breakthrough vaccine... View Details
Keywords: Vaccine; Production; Supply Chain; Product; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Belgium
Related
  • March 2010 (Revised May 2012)
  • Case

Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration

By: Karim R. Lakhani and Paul R. Carlile
This case presents the Myelin Repair Foundation's accelerated research collaboration model for drug discovery. It highlights the challenges of building a multi-disciplinary and multi-institutional research collaboration that is attempting to create a treatment for... View Details
Keywords: Research and Development; Intellectual Property; Risk and Uncertainty; Strategic Planning; Collaborative Innovation and Invention; Health Disorders; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
Related
  • 26 Jul 2010
  • Research & Ideas

Yes, You Can Raise Prices in a Downturn

almost any business action, especially in tough and uncertain economic conditions when price is a key and visible strategic choice. Conventional wisdom has firms cutting price in these circumstances. But most industries typically allow... View Details
Keywords: by Sean Silverthorne; Retail; Consumer Products
  • December 1999
  • Case

Agrochemicals at Ciba-Geigy AG (A)

By: Michael L. Tushman, Wendy Smith and Daniel Radov
After spending five years to develop a revolutionary product, the director of Ciba-Geigy's fungicide research department is handed an unfavorable market study. The case details the R&D process for the new product, including information on corporate partnerships,... View Details
Keywords: Agribusiness; Plant-Based Agribusiness; Research and Development; Innovation and Invention; Innovation Strategy; Product Launch; Marketing Channels; Change Management; Product Development; Business Processes; Organizational Structure; Corporate Accountability; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry
Related
  • July 2014 (Revised February 2015)
  • Teaching Note

Johnson & Johnson: The Promotion of Wellness

By: John A. Quelch
The chief medical officer of Johnson & Johnson (J & J) is reflecting on forty years of sustained efforts by the company to improve employee wellness. The case reviews J & J's multiple wellness initiatives and efforts to measure their effectiveness. It also invites... View Details
Keywords: Empoylee Wellness Programs; Human Resource Management; Corporate Management Strategy; Employee Engagement; Human Resources; Management; Organizations; Performance; Personal Development and Career; Programs; Strategy; Health Industry; Health Industry; Health Industry; Health Industry; North and Central America; Europe; Asia
Related
  • March 2015
  • Teaching Note

CVS Health: Promoting Drug Adherence

By: Leslie John, John Quelch and Robert Huckman
Email mking@hbs.edu for a courtesy copy.

This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details
Keywords: Medication Adherence; Affordable Care Act (ACA); Marketing Strategy; Communication Strategy; Customer Value and Value Chain; Decisions; Health Care and Treatment; Goals and Objectives; Resource Allocation; Marketing Communications; Consumer Behavior; Measurement and Metrics; Service Delivery; Behavior; Motivation and Incentives; Social Issues; Information Technology; Value Creation; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States
Related
  • 05 Sep 2007
  • First Look

First Look: September 5, 2007

findings, we consider both information and social factors. We find that firms are more likely to protect proximate employees in soft information industries (i.e., when information is difficult to transfer over long distances). However,... View Details
Keywords: Martha Lagace
  • 18 Dec 2012
  • First Look

First Look: December 18

assumptions are present in the structure of technology and labor flows within Silicon Valley and its surrounding areas. Our model further identifies how the lengths over which agglomerative forces operate influence the shapes and sizes of View Details
Keywords: Carmen Nobel
  • 01 Sep 2012
  • News

What’s the Big Idea?

international divisions. “Goldman Sachs in New York is different from Goldman Sachs in Asia,” he observes, adding that the same is true for conglomerates operating in industries as different as View Details
Keywords: Garry Emmons;Julia Hanna;Roger Thompson; Corporate Services; Colleges, Universities, and Professional Schools; Educational Services; Management
  • July 2017 (Revised July 2019)
  • Supplement

"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (B)

By: Nori Gerardo Lietz and Ricardo Andrade
The B Case of "Dr. My Eyes" provides the answer as to what happened after the ending fact pattern in Case A and the imminent choices faced by the protagonist in the primary case. At the end of the Case A, Bess Weatherman of Warburg Pincus, must chose one option of two... View Details
Keywords: Private Equity; Health Care and Treatment; Mergers and Acquisitions; Corporate Governance; Decision Choices and Conditions; Outcome or Result; Health Industry; Health Industry; Health Industry
Related
  • July 2016 (Revised July 2019)
  • Teaching Plan

Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz and Ricardo Andrade
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Health Industry; Health Industry; Health Industry; United States
Related
  • April 2016 (Revised July 2019)
  • Case

"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
Keywords: Health Care; Mergers ＆ Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Corporate Governance; Health Care and Treatment; Reports; Business Model; Health Industry; Health Industry; Health Industry; United States
Related
  • 10 Jan 2005
  • Research & Ideas

Motivation and the Cross-Sector Alliance

government blames the industrial sector, thus holding manufacturers responsible. The upcoming period of legislative meetings will tackle the new law on containers and packages. There are several proposals, and the last version I have... View Details
Keywords: by James Austin, Ezequiel Reficco & SEKN research team
  • 20 Jan 2015
  • First Look

First Look: January 20

industries and headquartered in 45 countries during the years 2004 to 2007. Results show that firms that are more environmentally damaging, particularly those in countries where they are more exposed to scrutiny and global norms, are less... View Details
Keywords: Sean Silverthorne
  • 24 Feb 2009
  • First Look

First Look: February 24, 2009

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=909036 Esser & Ackermann at Mannesmann Harvard Business School Case 209-095 No abstract is available at this time. Purchase this case:... View Details
Keywords: Martha Lagace
  • August 2003
  • Teaching Note

Pharmacyclics: Financing Research and Development (TN)

By: Malcolm P. Baker and Richard S. Ruback
Teaching Note for (9-201-056). View Details
Keywords: Pharmaceutical Industry; Pharmaceutical Industry
Related
  • 20 Feb 2018
  • First Look

First Look at New Research and Ideas, February 20, 2018

that suppliers that extend significant amounts of trade credit hold private information about their trade partners. Trade creditors who are geographically closer or in similar industries tend to lend the most, suggesting that these are... View Details
Keywords: Sean Silverthorne